• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
Home » Medication may benefit older adults with anxiety disorder

Medication may benefit older adults with anxiety disorder

Study finds antidepressant escitalopram can improve symptoms, quality of life

January 29, 2009

Many older adults worry—a lot. Almost one in 10 Americans over age 60 suffers from an anxiety disorder that causes them to worry excessively about normal things, such as health, finances, disability, and family. Although antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) can improve anxiety symptoms in younger adults, little has been known about their effects in older people.

In what's touted to be the largest study of SSRIs in older people with anxiety disorders, a team of psychiatric researchers found that the drug escitalopram, which is sold under the brand name Lexapro, improved anxiety symptoms and quality of life. Results of the study are reported in the Jan. 21 issue of the Journal of the American Medical Association.

Patients who participated in the study suffer from what's called generalized anxiety disorder (GAD), one of the most common psychiatric disorders in older adults. It's defined by chronic, difficult-to-control worry and anxiety, with related symptoms such as muscle tension, sleep disturbance, and fatigue. Because the number of older adults in the U.S. is growing and there is a lack of effective treatment, GAD is expected to become an increasing human and economic burden, according to background information in the article.

"A person with generalized anxiety disorder spends, on average, about 40 hours a week worrying, so it's almost like having a full-time job," says principal investigator Dr. Eric J. Lenze, associate professor of psychiatry at Washington University School of Medicine, in St. Louis. "They worry about very real things, but the inability to put those worries out of their minds makes the condition disabling."

Older adults with anxiety disorders typically either aren't treated or are prescribed sedative drugs known by trade names such as Valium and Xanax. Sedatives can relieve anxiety, but their long-term use in older adults is linked to falls and cognitive impairment. SSRI drugs are thought to be a safer alternative, but it wasn't clear if they could reduce anxiety in this age group.

Lenze led the study while at the University of Pittsburgh. His team studied 177 people over the age of 60, with an average age of about 73.

Half received the SSRI drug escitalopram, and the rest took an inactive placebo. Participants took one pill per day. If their symptoms didn't improve after four weeks, a second pill was added. In patients receiving the drug, taking two pills increased the dosage from 10 milligrams to 20 milligrams, and the higher dose reduced anxiety more effectively.

After 12 weeks of treatment, 68 percent of patients taking escitalopram had improved. About 51 percent of those taking the placebo showed improvement.

"We found improvements not only in anxiety and level of worry but also in functioning," Lenze says. "Many people who took the drug felt they were better able to carry out daily role activities related to their work or family life."

Interestingly, the researchers also noted that escitalopram helped some patients lower blood pressure.

"We noticed if their blood pressure was normal, it stayed the same. If they had high blood pressure, it got better," he says. "It's a preliminary finding, and more research is needed, but it suggests that anxiety treatment in this age group can help with other health problems."

The main side effect of escitalopram in this study was fatigue and sleepiness. That surprised the research team because the drug is not a sedative; yet, the symptoms usually went away after a few weeks, and the drug was well tolerated overall.

Although escitalopram helped, Lenze calls the benefits modest.

"That doesn't mean an older adult shouldn't take an SSRI for an anxiety disorder, but it appears the medication alone usually won't be sufficient," he says. "We're currently conducting a study that combines drug treatment with a type of psychotherapy called cognitive behavior therapy."

That study includes investigators at the University of Pittsburgh, the University of California at San Diego, and Washington University.

This study treats patients for 56 weeks. Lenze believes the long-term nature of the study will provide better answers about how to treat anxiety in older adults effectively and whether doing so improves health.

"Most older adults with an anxiety disorder never see a mental health specialist," Lenze says. "They are more likely to see a gastroenterologist for GI difficulties or a rheumatologist for muscle pain than to go to a psychiatrist. They may feel stress and worry about things, but some other symptom is what gets them to go to the doctor."

    Latest News
    • Related Articles

      Anxiety disorder outpaces related women's health issues

      When older adults go back to school

      Self-esteem falls off sharply among older adults

    Daily News Updates

    Subscribe today to our free E-Newsletters!

    SUBSCRIBE

    Featured Poll

    What is Spokane's most iconic historic building?

    Popular Articles

    • Stephanie vigil web
      By Karina Elias

      Catching up with: former news anchor Stephanie Vigil

    • Rite aid3 web
      By Journal of Business Staff

      Two Spokane Rite Aid stores to close

    • 40.13 fc art
      By Tina Sulzle

      $165 million development planned at CDA National Reserve

    • Stcu ceo lindseymyhre web
      By Journal of Business Staff

      STCU names new president, CEO

    • Centennial lofts
      By Erica Bullock

      Large Spokane Valley residential project advances

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2025 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing